GlassScriptPhysician profile
Wesley J Lewis
NPI 1013932144
$4,516.65
in general payments reported to CMS, 2019-2025
49 companies · $657 in 2025
The $657 reported for 2025 was more than what 86% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $211 · 2021: $550 · 2022: $845 · 2023: $859 · 2024: $828 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,233.24 | 2020-2025 | |
| Lilly USA, LLC | $479.01 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.68 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $236.92 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Abbott Laboratories | $208.04 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Dynavax Technologies Corporation | $205.34 | 2019-2025 | Heplisav-B |
| Merck Sharp & Dohme LLC | $134.38 | 2021-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Pfizer INC. | $111.29 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.15 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $97.82 | 2019-2023 | Breztri |
| Gilead Sciences, INC. | $85.70 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $85.66 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.18 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $77.56 | 2022-2023 | |
| Corium, LLC | $70.54 | 2024 | Azstarys |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $69.07 | 2019-2023 | Krystexxa |
| Novo Nordisk INC | $60.85 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Nevro Corp. | $59.95 | 2019-2021 | |
| Astellas Pharma US INC | $56.41 | 2019-2025 | Veozah |
| Seqirus USA INC | $53.29 | 2019-2025 | Fluad, Flucelvax |
| Janssen Pharmaceuticals, INC | $49.61 | 2020-2022 | |
| Amgen INC. | $45.05 | 2019 | |
| Boston Scientific Corporation | $44.20 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Quidel Corporation | $40.84 | 2019 | |
| Corcept Therapeutics | $32.14 | 2024 | Korlym |
| Allergan, INC. | $31.62 | 2019-2020 | |
| Lucid Diagnostics INC. | $28.68 | 2021-2022 | |
| Genentech USA, INC. | $28.31 | 2020-2021 | |
| Hologic Sales and Service, LLC | $27.76 | 2022 | |
| Medtronic, INC. | $27.32 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $26.77 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $25.29 | 2022-2023 | Quviviq |
| Organon LLC | $23.26 | 2025 | Nexplanon |
| Radius Health, INC. | $20.27 | 2025 | Tymlos |
| Viiv Healthcare Company | $19.77 | 2025 | Apretude |
| Treace Medical Concepts, INC. | $18.59 | 2024 | |
| Shire North American Group INC | $18.28 | 2019 | |
| Si-Bone, INC. | $18.03 | 2025 | |
| Recor Medical INC | $17.94 | 2025 | Paradise Ultrasound Renal Denervation System |
| Smith+Nephew, INC. | $17.44 | 2025 | Grafix |
| Ultragenyx Pharmaceutical INC. | $17.04 | 2022 | |
| Inspire Medical Systems, INC. | $16.68 | 2025 | Inspire |
| Sonex Health, INC. | $16.64 | 2025 | Sx-One Microknife |
| Daiichi Sankyo INC. | $15.29 | 2020 | |
| Axsome Therapeutics, INC. | $14.59 | 2023 | Auvelity |
| Sanofi Pasteur INC. | $14.21 | 2019 | |
| Axonics, INC. | $13.20 | 2022 | |
| Esperion Therapeutics, INC. | $12.07 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.